跳至主要内容
临床试验/IRCT20160530028182N9
IRCT20160530028182N9已完成2 期

Evaluation of the effectiveness of etentalin, Ahura hyperactive and risperidone syrups in preschool children with attention deficit hyperactivity disorder (ADHD)

Sanandaj University of Medical Sciences0 个研究点目标入组 57 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
57

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
3 years 至 6 years(—)
性别
All

入选标准

  • The age range of these children is 3 to 6 years
  • According to the DSM-5 diagnostic criterion, the child and adolescent psychiatrist should diagnose ADHD in children.

排除标准

  • The presence of a serious physical illness, such as a seizure, based on parental history and clinical suspicion
  • Existence of comorbid psychiatric disorder other than confrontational disobedience disorder
  • Mental retardation based on clinical suspicion
  • Taking medications for Attention Deficit Hyperactivity Disorder in the last month
  • History of allergy to ethenalin and Ahura hyperactive

研究者

发起方
Sanandaj University of Medical Sciences

相似试验

未知
2 期
A study to evaluate the efficacy of Eribulin retreatment in HER2 negative Metastatic Breast Cancer patients - Phase II studyHER2-negative metastatic breast cancer
JPRN-UMIN000027165Toho university30
进行中(未招募)
1 期
Evaluation de l’efficacité de l’Alfentanil chez l’enfant en réanimation infantile par rapport au Sufentanil - traitement de référence - sur le confort du patient lors de l’aspiration trachéale - DOLOREA PEDIAconfort de l'enfant lors de l'aspiration trachéale en réanimation pédiatrique
EUCTR2009-017274-20-FRCentre Hospitalier Universitaire de GRENOBLE
尚未招募
2 期
To evaluate the efficacy and safety of Erlotinib and Bevacizumab in patients with advanced Non-squamous Non-Small Cell Lung Cancer with brain metastasis who acquired resistance to prior EGFR-TKI treatment harboring EGFR mutation.on-Small-Cell Lung Cancer
JPRN-UMIN000012515Department of Respiratory Medicine, Kumamoto University Hospital16
招募中
2 期
A Study to Assess the Effects of the Endothelin Receptor Antagonist Zibotentan and the SGLT2 Inhibitor Dapagliflozin in Patients elevated Albuminuria: a Randomized Double Blind Cross-Over Trialdiabetic kidney disease1001265310029149diabetic nephropathy
NL-OMON54022niversitair Medisch Centrum Groningen12
进行中(未招募)
1 期
A Study to Assess the Effects of the drugs Zibotentan and Dapagliflozin in Patients with Elevated Levels of Protein in UrinePatients with elevated AlbuminuriaMedDRA version: 21.1Level: PTClassification code 10061835Term: Diabetic nephropathySystem Organ Class: 10038359 - Renal and urinary disordersMedDRA version: 20.0Level: PTClassification code 10016807Term: Fluid retentionSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 20.0Level: PTClassification code 10001580Term: AlbuminuriaSystem Organ Class: 10038359 - Renal and urinary disorders
EUCTR2021-001324-18-NLniversity Medical Center Groningen38